A NOVEL METHOD FOR REGIONAL CITRATE ANTICOAGULATION IN CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVHF)

REFERENCES

• Clark W.R., Alaka K.J., Mueller B.A., Macias W.L. A Comparison of Metabolic Control by Continuous and Intermittent Therapies in Acute Renal Failure. J. Am. Soc. Nephrol. 1994; 4: 1413–1420
   Google Scholar
• van Bommel E., Bouvy N.D., So K.L., Zietse R., Vincent H.H., Bruining H.A., Weimar W. Acute Dialytic Support For the Critically Ill: Intermittent Hemodialysis Versus Continuous Arteriovenous Hemodiafiltration. Am. J. Nephrol. 1995; 15: 192–200
   Google Scholar
• van de Wetering J., Westendorp R.G., van der Hoeven J.G., Stolk B., Feuth J.D., Chang P.C. Heparin Use in Continuous Renal Replacement Procedures: The Struggle Between Filter Coagulation and Patient Hemorrhage. J. Am. Soc. Nephrol. 1996; 7: 145–150
   Google Scholar
• Ward D.M., Mehta R.L. Extracorporeal Management of Acute Renal Failure Patients at High Risk of Bleeding. Kidney Int. 1993; 43(Suppl. 41)S237–S244
   Google Scholar
• Mehta R.L. Anticoagulation During Continuous Renal Replacement Therapy. ASAIO J. 1994; 40: 931–935
   Google Scholar
• DePont A.C., Oudemans-vanStraaten H.M., Roozendaal K.J., Zandstra D.F. Nadroparin Versus Dalteparin Anticoagulation in High-Voluem, Continuous Venovenous Hemofiltration: A Double Blind Randomized Crossover Study. Crit. Care Medicine 2000; 28: 421–425
   Google Scholar
• Beholz S., Grubitzsch H., Bergmann B., Wollert H.G., Eckel L. Anticoagulation in Extracorporeal Circulation Using Recombinant Hirudin: A Case Report. Perfusion 2000; 15: 257–260
   Google Scholar
• Zusman R.M., Rubin R.H., Cato A.E., Cocchetto D.M., Crow J.W., Tolkoff-Rubin N. Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic Agent. New Engl. J. Med. 1981; 304: 934–939
   Google Scholar
• Swartz R.D. Hemorrhage During High-Risk Hemodialysis Using Controlled Heparinization. Nephron 1981; 28: 65–69
   Google Scholar
• Tan H.K., Baldwin I., Bellomo R. Continuous Veno-Venous Hemofiltration Without Anticoagulation in High-Risk Patients. Intensive Care Med. 2000; 26: 162–165
   Google Scholar
• Mehta R.L., McDonald B.R., Aguilar M.M., Ward D.M. Regional Citrate Anticoagulation for Continuous Arteriovenous Hemodialysis in Critically Ill Patients. Kidney Int. 1990; 38: 976–981
   Google Scholar
• Palsson R., Nilesm J.L. Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients with a High Risk of Bleeding. Kidney Int. 1999; 55: 1991–1997
   Google Scholar
• Flanigan M.J., Von Brecht J., Freeman R.M., Lim V.S. Reducing the Hemorrhagic Complications of Hemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate Anticoagulation. Am. J. Kidney Dis. 1987; 9: 147–153
   Google Scholar
• Kaplan A.A., Longnecker R.E., Folkert V.W. Continuous Arteriovenous Hemofiltration: A Report of Six Months Experience. Ann. Intern. Med. 1984; 100: 358–367
   Google Scholar
• Cook D., Heyland D., Griffith L., Cook R., Marshall J., Pagliarello J. Risk Factors for Clinically Important Upper Gastrointestinal Bleeding in Patients Requiring Mechanical Ventilation. Canadian Critical Care Trials Group. Crit. Care Med. 1999; 27: 2812–2817
   Google Scholar
• Kutsogiannis D.J., Mayers I., Chin W.D., Gibney R.T. Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration. Am. J. Kidney Dis. 2000; 35: 802–811
   Google Scholar
• Mehta R.L., Pascual M.T., Zhuang S. for the ARF Collaborative Study Group: Citrate Anticoagulation (CIT) for Continuous Renal Replacement Therapy (CRRT). J. Amer. Soc. Nephrol. 2000; 11: 325A, abstract
   Google Scholar
• Stefanidis I., Hagel J., Frank D., Maurin N. Hemostatic Alteration During Continuous Venovenous Hemofiltration in Acute Renal Failure. Clin. Nephrol. 1996; 46: 199–205
   Google Scholar
• Davenport A. The Coagulation System in the Critically Ill Patient with Acute Renal Failure and the Effect of an Extracorporeal Circuit. Amer. J. Kidney Dis. 1997; 30(Suppl 4)S20–S27
   Google Scholar
• Cardigan R.A., McGloin H., Mackie I.J., Machin S.J., Singer M. Activation of the Tissue Factor Pathway Occurs During Continuous Venovenous Hemofiltration. Kidney Int. 1999; 55: 1568–1574
   Google Scholar
• Ronco C., Bellomo R., Homel P., Brendolan A., Dan M., Piccinni P., La Greca G. Effects of Different Doses in Continuous Veno–Venous Hemofiltration on Outcomes of Acute Renal Failure: A Prospective Randomized Trial. Lancet 2000; 356: 26–30
   Google Scholar
• Böhler J., Schollmeyer P., Dresseel B., Dobos G., Hörl W.H. Reduction of Granulocyte Activation During Hemodialysis with Regional Citrate Anticoagulation: Dissociation of Complement Activation and Neutropenia from Neutrophil Degranulation. J. Amer. Soc. Nephrol. 1996; 7: 234–241
   Google Scholar